AFT PHARMACEUTICALS LIMITED
ASX:AFPPharmaceuticals, Biotechnology & Life SciencesToday’s holders own 99.4% of what they think they own, once every option and right converts.
No issuance filings since 2024; no dilution pressure signals in current disclosures
AFT PHARMACEUTICALS LIMITED has 105M ordinary shares as of June 2026. No new share issuances have been filed since January 2024. The company has not undertaken any capital raises in the past 24 months, and no proposed securities issues are pending. Options and rights on issue could convert to 651,000 new shares, representing 0.6% of the current share count, with none of these currently in the money. No expiry date for these securities has been filed, and no current quarterly cash report is on record to provide a cash balance or funding runway figure.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 1 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 21 June 2026 | 2A · quoted issue | AFP : ORDINARY FULLY PAID FOREIGN EXEMPT NZX | 104.9M | Appendix 2A |
Capital raises
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 allows 15% of ordinary securities in any 12 months, and every Appendix 3B states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
No option supply on record carries an exercise price to pay, so no share price switches any of it on. All 651k of it converts on something else — a hurdle that may never be met, or terms the filing does not price.
| Code | Security | Type | Exercise price | Expiry | On issue | Source |
|---|---|---|---|---|---|---|
| AFPAB | Options | Price-triggered | — | — | 651k | Filing |
“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column.
Director dealings
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 12 Sept 2026.